ChemoCentryx
CCXI
#3553
Rank
C$5.17 B
Marketcap
C$72.00
Share price
0.00%
Change (1 day)
30.90%
Change (1 year)

EPS for ChemoCentryx (CCXI)

EPS in 2022 (TTM): C-$2.40

According to ChemoCentryx's latest financial reports the company's current EPS (TTM) is C-$2.62. In 2021 the company made an earnings per share (EPS) of C-$2.62 a decrease over its 2020 EPS that were of C-$1.12.

EPS history for ChemoCentryx from 2012 to 2022

Annual EPS

Year EPS Change
2022 (TTM)C-$2.40-8.35%
2021C-$2.62133.33%
2020C-$1.12-16.49%
2019C-$1.3427.63%
2018C-$1.05-305.41%
2017C$0.51-142.53%
2016C-$1.20-19.44%
2015C-$1.50-0%
2014C-$1.5013.68%
2013C-$1.32-16.67%
2012C-$1.58

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Biogen
BIIB
C$15.22-681.48%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
C$1.87-171.53%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
C$4.98-290.26%๐Ÿ‡ฌ๐Ÿ‡ง UK
Bristol-Myers Squibb
BMY
C$4.11-257.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
C$14.46-652.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$18.05-789.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$2.38-191.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
C$0.87-133.33%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Merck
MRK
C$10.52-501.79%๐Ÿ‡บ๐Ÿ‡ธ USA